# A Pilot Clinical Study to Evaluate the Feasibility of Using the SPC Test

> **NCT06521528** · — · ACTIVE_NOT_RECRUITING · sponsor: **Novomics. Co., Ltd.** · enrollment: 237 (actual)

## Conditions studied

- Gastric Cancer

## Interventions

- **DEVICE:** nProfiler I Stomach Cancer Assay Kit

## Key facts

- **NCT ID:** NCT06521528
- **Lead sponsor:** Novomics. Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-09-01
- **Primary completion:** 2020-08-30
- **Final completion:** 2025-12-31
- **Target enrollment:** 237 (ACTUAL)
- **Last updated:** 2024-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06521528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06521528, "A Pilot Clinical Study to Evaluate the Feasibility of Using the SPC Test". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06521528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*